Clinical medicine (London, England) · 2010
How to reduce morbidity and mortality from chest infections in rheumatoid arthritis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Housden M M, Bell G, Heycock C R, Hamilton J, Saravanan V, Kelly C A
Аннотация
Morbidity and mortality from pneumonia is increased in patients with rheumatoid arthritis. Factors contributing to this have been recently identified and a number of recommendations have been implemented in an attempt to reverse this trend. The present paper shows that these measures have combined to produce a fourfold reduction in both admissions and case fatality rates. In the study population, immunisation rates against influenza and pneumococcus have improved to 86% and 65%, oral steroid consumption has halved and disease modifying drugs were usually appropriately suspended during acute infection. These measures may now merit more widespread adoption.
Предметные рубрики MeSH
AgedAntirheumatic AgentsArthritis, RheumatoidClinical ProtocolsFemaleGlucocorticoidsGranulocyte Colony-Stimulating FactorHumansInfluenza VaccinesLeucovorinLeukocyte CountMaleMiddle AgedNeutropeniaPatient AdmissionPneumococcal VaccinesPrednisoneRespiratory Tract InfectionsRisk FactorsUnited KingdomVaccinationVitamin B Complex